Home > Insider Trading > Merck Sharp & Dohme Corp.

Merck Sharp & Dohme Corp. (MRK)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Analyst Says Merck (MRK) is ‘Really Cheap’ But Warns About Potential ‘Bad News’

Bill Stone, Glenview Trust Company chief investment officer, mentioned his bullish take on Merck (NYSE:MRK) during a recent program on CNBC and explained the potential risks and rewards tied to the stock...

Keep Reading →

June 5th, 2025 - News

Merck & Co., Inc. (MRK) Held Talks Over $3 Billion Acquisition of Swiss Biotech Firm MoonLake

Although the initial proposal was turned down, talks may resume. Merck & Co., Inc.

Keep Reading →

June 2nd, 2025 - News

Gilead Sciences, Inc, (GILD)’s Trodelvy and Merck & Co., Inc, (MRK)’s Keytruda Cuts Breast Cancer Progression Risk by 35%

A new clinical trial has shown that combining Gilead Sciences, Inc. (NASDAQ:GILD)’s Trodelvy with Merck & Co., Inc.

Keep Reading →

May 31st, 2025 - News

Merck & Co., Inc. (MRK)’s MK-1084 Shows Promise in Early Cancer Trial

Merck & Co., Inc.

Keep Reading →

May 31st, 2025 - News

Merck & Co., Inc. (MRK) Reports Positive Trial Results for DLBCL Drug

Merck & Co., Inc.

Keep Reading →

May 31st, 2025 - News

Jim Cramer on Merck & Co (MRK): ‘I’ve Got To Take a Hard Look At It’

Jim Cramer in a recent program on CNBC commented on Merck & Co Inc.

Keep Reading →

May 30th, 2025 - News

Here’s Why Merck & Co. (MRK) Traded Lower in Q1

Artisan Partners, an investment management company, released its “Artisan Value Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

May 30th, 2025 - Hedge Fund Investor Letters News

Merck & Co., Inc. (MRK): A Bull Case Theory

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Value Investing Subreddit Page by CompanyCharts. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.

Keep Reading →

May 21st, 2025 - News Stock Analysis

10 Stocks Everyone’s Talking About as Trump Blinks in Trade War

Chris Toomey, Morgan Stanley managing director of private wealth, said in a latest program on CNBC that he is not bullish on stocks yet and plans to “stay defensive” until a few key issues are resolved...

Keep Reading →

May 19th, 2025 - Hedge Funds News